Overview

Ascendis Pharma A/S is a biopharmaceutical company that leverages its proprietary TransCon technology to address unmet medical needs in endocrinology and oncology. The company's innovative approach aims to generate best-in-class therapies, providing sustained release of the active compound.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Ascendis Pharma A/S in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.